The House of Representatives approved the legislation in a 155-0 vote on Wednesday. If the Senate goes ahead, expected this week, the proposal would go to the desk of Gov. Maura Healey (D), who could sign it or veto it, making it law without her signature or proposing amendments for lawmakers to consider.
A bicameral conference committee spent months working on provisions of the legislation after the two chambers passed different versions last year, and the committee approved the compromise approach on Monday.
“The conference committee’s report lays out an excellent road map for the future structure of cannabis regulation in the commonwealth,” said Rep. Daniel M. Donahue (D), who chaired the bicameral panel, before the vote on the House floor.
Changes to the state’s cannabis regulatory structure will “create better accountability, better transparency and greater efficiencies in the oversight of our cannabis industry,” he said. “We also worked on some massive regulatory changes for the industry. I think some of these regulatory changes have been a long time coming, and that’s why we should be proud that we’re doing it to help our businesses.”
Donahue and Sen. Adam Gómez (D), who chaired the conference committee, said in a joint statement earlier this week that the agreement “charts a more hopeful path forward for the regulation of cannabis in our commonwealth.”
“The bill creates new opportunities for small businesses to grow, while providing temporary and exclusive access to those opportunities for those historically harmed by marijuana laws,” said the lawmakers, who also serve as chairs of the House Joint Cannabis Policy Committee. “This bill will allow them to realize their capital and achieve innovative models such as employee businesses.”
Among the revisions to the state’s cannabis law is a section that would increase the personal possession limit of marijuana from one ounce to two. Colorado enacted the same reform in 2021 after the state’s cannabis market matured.
H.5350 would reduce the size and reorganize the Cannabis Control Commission (CCC), while also updating the limits on marijuana business licenses.
According to the versions of both chambers invoiceThe CCC would consist of three members instead of the current five. Conference committee the report It adopts provisions of the House measure that would allow the governor to make all the appointments, with the Senate approach giving the attorney general one of the appointments. Under current legislation, the treasurer also has a role in appointing committee members, but this will not be the case if the legislation comes into force.
The proposal calls for one member of the CCC to have a background in social justice, while the other two commissioners have a background in public health, public safety, social justice, consumer regulation or the production and distribution of cannabis.
The bill will also increase the number of licenses a single entity can hold from three to six, and also raise from 10 percent to 20 percent the threshold for how much of a company’s equity is considered property to count toward the license cap. It also removes a current requirement that medical cannabis operators be vertically integrated to simultaneously cultivate, manufacture and sell marijuana.
It also empowers regulators to choose dispensaries to advertise sales, discounts and customer loyalty programs at retail locations and via email, and specifies that marijuana dispensary operators can deliver to any municipality unless local officials proactively ban cannabis businesses and stop delivery.
The measure creates a new portal for reporting illegal behavior and directs regulators to create a list of cannabis companies that have not paid their debts to other operators for more than 60 days and prevents regulators from doing business with other operators until the debts are settled.
The legislation also requires regulators to study and report on hemp-derived products, the public health impacts of cannabis, tax policy and workplace safety regulations.
If approved, the state would not return to general prohibition; rather, it would repeal the commercial recreational sales and home cultivation components of the law, while allowing adults 21 and older to possess one ounce of cannabis for personal use.
Possession of more than one ounce but less than two ounces would effectively be decriminalized, with violators facing a $100 fine. Adults can also continue to gift cannabis to each other without payment. The sale of medical marijuana would be legal.
The measure is before the legislature after supporters provided an initial round of signatures last year, and lawmakers have until May 5 to act on the proposal. If they decide not to pass it in the legislature, the campaign would have to go through another round of petitions and get at least 12,429 certified signatures by July 1 to get on the November ballot.
Regulators should also examine marijuana’s effectiveness in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). In addition, police and first responders in other jurisdictions will review laws and policies regarding the use of cannabis and “any other matter deemed relevant by the commission.”
A report by the Cannabis Control Commission (CCC) found that legalization is achieving one of its main goals: stopping the illegal sale of cannabis as adults move into the regulated market. It shows that among adults who used marijuana in the past year, a staggering 84 percent said they got their cannabis from a licensed source.
Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.
Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.
With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.
Rep. James Comer (R-KY) introduced the delay proposal as an amendment to the Farm Bill, while Rep. Mary Miller (R-IL) introduced an expedited approach. Neither will move forward, however, with Comer withdrawing his measure and the House Rules Committee failing to vote on Miller’s.
Hemp derivatives containing less than 0.3 percent delta-9 THC by weight of the drug were made federally legal under the 2018 Farm Bill signed by President Donald Trump in his first term. But late last year, Trump signed new legislation containing provisions that will redefine hemp so that only products with a total of 0.4 milligrams of THC per container will be legal starting Nov. 12.
Comer’s amendment, sponsored by Reps. Kelly Morrison (D-MN), Ilhan Omar (D-MN) and Morgan Griffith (R-VA), would have delayed the ban until November 2027.
According to Miller’s proposal, however, the ban will begin the day the new Farm Bill takes effect. However, it is unclear based on progress in Congress whether the large-scale farming legislation will actually become law, and the legislation could not pass until after the current recriminalization date.
Comer told the panel at Monday’s meeting that his amendment would “protect American farmers” and “help the hemp industry and the thousands of jobs that use and rely on these products.”
“It is clear that Congress needs more time to pass legislation that protects jobs, eliminates bad actors, standardizes labeling and requires third-party testing,” he said. “My amendment would give Congress another year, until November 2027, to develop this solution.”
It is not clear why he decided to remove it from the annex to the proposal Farm BillAlso known as the Farm, Food, and National Security Act of 2026, or HR 7567.
Griffith, a member of the Rules Committee who sponsored Comer’s amendment, noted that there are “a lot of hemp products from overseas that don’t have third-party testing” on the market, “frankly all kinds of junk.”
He said the real solution is for the Food and Drug Administration (FDA) to regulate the products, citing a separate bill he has introduced on the issue, but argued that “we have to have time to adjust,” which he said would provide the delay amendment.
Meanwhile, Rep. Andy Barr (R-KY) also introduced an amendment to the bill that, according to the sponsor’s summary, “changes the definition of hemp to protect the legal hemp market, creating a regulatory framework that protects children, bans synthetics, and ensures that products on the market are of American origin.”
The congressman later withdrew the proposal for undisclosed reasons.
Last week, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Barr, who is helping lead efforts to establish regulations for the plant as an alternative to prohibition.
“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.
“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”
The annex to the administration’s proposed legislative text has not been released publicly, and the White House and Barr’s office did not immediately respond to Marihuana Moment’s request for more details.
It’s not clear from the text of the letter whether the White House was proactively sending legislative proposals to the lawmaker or whether they were responding to something sent by his office, though two cannabis industry sources suggested to Marihuana Moment that Barr was sending the language to the administration, and then providing technical feedback.
“I’m calling on Congress to update the Act so Americans can continue to have access to the full-spectrum CBD products they trust and support, while maintaining Congress’ intent to restrict the sale of products that pose health risks,” the president said in a Truth Social message Thursday, the same day his administration announced it is moving forward to re-regulate marijuana.
“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”
The Farm Bill passed by the previous committee includes provisions to help the hemp industry and farmers who grow cannabis for industrial purposes, such as fiber and grain. For example, the legislation would amend statutes related to states and tribes developing regulatory plans for industrial hemp production, including policies on testing, sampling, background checks and record keeping.
Other bipartisan hemp reform bills are pending in Congress.
Ernst withdrew his name, however, as a sponsor of the legislation. His office did not respond to Marihuana Moment’s request for clarification on the move.
As hemp products become more popular among consumers, some big brands are trying to get in on the action.
The main retailer Target, for example, is expanding its involvement in the hemp-derived THC beverage market. Last year, the company began a pilot program in 10 stores in Minnesota that sell cannabis drinks. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
North Carolina lawmakers say they’re fueling debate over the state’s marijuana laws — a move by the Trump administration to reclassify it as a less dangerous drug.
Across the country, a set of laws and enforcements regulate marijuana. The drug is illegal under federal law, but dozens of US states have legalized it. And almost all states have legalized medical marijuana prescriptions for certain ailments. North Carolina is among the remaining states to resist any form of legalization. Republican politicians in North Carolina have resisted passing any bills to legalize or decriminalize marijuana, despite public opinion polls showing broad public support for such changes.
Senate President Phil Berger said he expects his chamber to revisit efforts to legalize medical marijuana this week. “We will have a conversation within our caucus if they are interested in whether we do something,” Berger told reporters Tuesday.
The recent actions of Republican President Donald Trump may add a new dimension to these conversations. Trump’s acting attorney general on Thursday signed the drug classification as a less dangerous and less strictly regulated drug than marijuana. Federal law does not legalize marijuana for medical or recreational use.